Who Owns Eton Pharmaceuticals Stock?
NASDAQ: ETONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:10 AM ET
Ownership breakdown
- Held by institutions
- 71.08%
- Held by insiders
- 4.89%
- Institutional holders
- 236
- Institutions 71.1%
- Insiders 4.9%
- Public and other 24.0%
Who owns Eton Pharmaceuticals stock?
Institutional investors own about 71.1% of Eton Pharmaceuticals's shares, spread across 236 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.89% of ETON.
The largest institutional holders are Opaleye Management Inc. (10.01%), EcoR1 Capital, LLC (7.60%) and Blackrock Inc. (6.63%). Together, the top 10 institutions control 42.7% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their ETON positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ETON
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Opaleye Management Inc. | 2.86M | 10.01% | 0.0% |
| EcoR1 Capital, LLC | 2.17M | 7.60% | 0.0% |
| Blackrock Inc. | 1.90M | 6.63% | +10.4% |
| Nantahala Capital Management, LLC | 1.18M | 4.11% | 0.0% |
| Vanguard Capital Management LLC | 976.57K | 3.42% | -1.8% |
| Morgan Stanley | 767.97K | 2.69% | +60.7% |
| State Street Corporation | 701.79K | 2.46% | +32.4% |
| Geode Capital Management, LLC | 652.30K | 2.28% | +12.9% |
| Oberweis Asset Management Inc. | 501.60K | 1.75% | +14.2% |
| National Philanthropic Trust | 492.11K | 1.72% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ETON
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 684.82K | 2.40% |
| iShares Trust-iShares Russell 2000 ETF | 683.55K | 2.39% |
| OBERWEIS FUNDS-Oberweis Micro-Cap Fund | 483.90K | 1.69% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 291.90K | 1.02% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 271.08K | 0.95% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 253.38K | 0.89% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 252.96K | 0.88% |
| iShares Trust-iShares Russell 2000 Growth ETF | 248.34K | 0.87% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 210.38K | 0.74% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 131.98K | 0.46% |
Frequently asked questions
Who is the largest shareholder of Eton Pharmaceuticals?
Opaleye Management Inc. is the largest institutional shareholder of ETON, owning 10.01% of shares outstanding (2.86M shares) as of its latest 13F filing.
What percentage of Eton Pharmaceuticals is owned by institutions?
Institutions own about 71.1% of ETON shares and 74.7% of the public float.
How much of Eton Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 4.89% of ETON shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.